Canbio Pharmaceuticals Llp - Due diligence report

A 360° intelligence report on Canbio Pharmaceuticals Llp: trust score, financial health, credit view, compliance, directors, growth and dist…

2020-06-12 Ahmedabad, Gujarat Active
Share
Connect MCP
CP Canbio Pharmaceuticals Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Canbio Pharmaceuticals Llp — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Canbio Pharmaceuticals Llp is assessed as Low Risk with a Trust Score of 77/100. Canbio Pharmaceuticals Llp is an active limited liability partnership incorporated in 2020, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 08 Oct 2026 from the latest processed filings. Canbio Pharmaceuticals Llp snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
40/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Profitable - internal accruals available.

Charges position: 3 open (7.15 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Icici Bank Limited2 48.0 cr
Bank Of Baroda1 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 40/100
NameDIN / PANDesignationAppointedTenureDIN status
BHUPENDRABHAI VALJIBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
RABINDRA KUMAR MOHANTY 01234567 Director 01/04/2018 6 yrs Approved
BHARATKUMAR VITTHALBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
PATHIK BHARATKUMAR SHELADIA 01234567 Director 01/04/2018 6 yrs Approved
HARSUKHBHAI JASMATBHAI VEKARIA 01234567 Director 01/04/2018 6 yrs Approved
KISHORKUMAR VRAJLAL RAKHOLIYA 01234567 Director 01/04/2018 6 yrs Approved
Dwij Kishorbhai Rakholiya 01234567 Director 01/04/2018 6 yrs Approved
Rahul Rajaram Kondekar 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • BHARATKUMAR VITTHALBHAI PATEL has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 3 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 3 year(s).
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 6 years.
Active GST registration(s).
Distress signals & risk flags
3 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 7.15 cr already registered.
  • Compliance record supports lending.
Investor view84/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
01 Aug 2025
Director appointed
Dwij Kishorbhai Rakholiya (Designated Partner)
Director appointed
Rahul Rajaram Kondekar (Designated Partner)
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
24 Dec 2024
Charge created
Icici Bank Limited - 75.00 Lakh
Charge created
Icici Bank Limited - 3.40 cr
03 Oct 2024
Director appointed
BHARATKUMAR VITTHALBHAI PATEL (Designated Partner)
Director appointed
KISHORKUMAR VRAJLAL RAKHOLIYA (Designated Partner)
Director ceased
BHUPENDRABHAI VALJIBHAI PATEL
Director ceased
ZANKAR VALLABHBHAI SAVALIA
Director ceased
PATHIK BHARATKUMAR SHELADIA
01 Sep 2022
Director appointed
PATHIK BHARATKUMAR SHELADIA (Designated Partner)
15 Feb 2021
Charge created
Bank Of Baroda - 3.00 cr
02 Sep 2020
Director appointed
RABINDRA KUMAR MOHANTY (Designated Partner)
01 Sep 2020
Director ceased
RABINDRA KUMAR MOHANTY
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 3 financial year(s).
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sarvdharam Sambhav Manavdharam Foundation U88900GJ2024NPL150556 Ahmedabad, Gujarat
Mitutronics Private Limited U31109GJ1993PTC020775 Ahmedabad, Gujarat
Avk Fab Metals Private Limited U43900GJ2024PTC148091 Ahmedabad, Gujarat
Pmt Valves Private Limited U29299GJ2019PTC107572 Ahmedabad, Gujarat
FLAWLESS VENTURE ENGINEERS LLP ABA-5542 Ahmedabad, Gujarat
LAXMIDEVI NAMKEEN AND SWEET LLP AAJ-2387 Ahmedabad, Gujarat
TVISHA TRADELINKS AND CONSULTANCY LLP AAA-5721 Ahmedabad, Gujarat
Alyssa Food Products Private Limited U10790GJ2024PTC150117 Ahmedabad, Gujarat
Hp Brothers Steel Private Limited U51909GJ2021PTC122490 Ahmedabad, Gujarat
Radhikas Spechem Private Limited U24290GJ2018PTC105664 Ahmedabad, Gujarat
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Canbio Pharmaceuticals Llp before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Canbio Pharmaceuticals Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Canbio Pharmaceuticals Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Canbio Pharmaceuticals Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Canbio Pharmaceuticals Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Canbio Pharmaceuticals Llp an active company?

Canbio Pharmaceuticals Llp has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Canbio Pharmaceuticals Llp financially healthy?

Canbio Pharmaceuticals Llp has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Canbio Pharmaceuticals Llp?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Canbio Pharmaceuticals Llp?

See the directors and ownership sections above for board and shareholding detail. 8 active director(s) are on record.

Does Canbio Pharmaceuticals Llp have loans or charges against its assets?

3 open charge(s) are registered against its assets.

Is Canbio Pharmaceuticals Llp up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Canbio Pharmaceuticals Llp?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.